AT
Albert Tauro
About Albert Tauro
Data last updated:
Albert Tauro is a Director at Centaur Pharmaceuticals Private Limited (since 2016). The companies operate in Pharma, Engineering and Real Estate and Construction. Centaur Pharmaceuticals Private Limited reported revenue of ₹1,060 Cr (FY 2025). Earlier, Albert Tauro was an Additional Director at Ashoka Buildcon Limited (2012) and Director at Viva Highways Limited (2015–2017) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Centaur Pharmaceuticals Private Limited U24230MH1980PTC023291 | Director | 11 Aug 2016 | 1980 | ₹1,060 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ashoka Buildcon Limited L45200MH1993PLC071970 | Additional Director | 18 May 2012 | 1993 | ₹7,704 Cr (FY 2026) | Active |
| Viva Highways Limited U45200MH2001PLC171661 | Director | 05 Sep 2015 | 2001 | ₹523 Cr (FY 2025) | Active |
| Ashoka Infrastructure Limited U45203MH2002PTC172229 | Director | 07 Sep 2015 | 2002 | ₹13.81 Cr (FY 2025) | Active |
| Kharar Ludhiana Road Limited U45309DL2016PLC304822 | Nominee Director | 08 Jan 2020 | 2016 | ₹115 Cr (FY 2023) | Active |
 Ranastalam Anandapuram Road Limited U45500DL2017PLC315722 | Nominee Director | 07 Jan 2020 | 2017 | ₹74.64 Cr (FY 2025) | Active |
 Cent Bank Home Finance Ltd U65922MH1991PLC471288 | Director | 08 Sep 2007 | 1991 | ₹162 Cr (FY 2024) | Active |
 Centbank Financial Services Limited U67110MH1929GOI001484 | Director | 27 Sep 2007 | 1929 | ₹5.29 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Albert Tauro
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pritam Maruti Khawale | Centaur Pharmaceuticals Private Limited | Company Secretary | |
| Rakhi Shridhar Kadam | 02898330 | Centaur Pharmaceuticals Private Limited | Whole-Time Director |
| Sharadchandra Damodar Abhyankar | 00108866 | Centaur Pharmaceuticals Private Limited | Director |
| Shivanand Dattatray Sawant | 00407965 | Centaur Pharmaceuticals Private Limited | Managing Director |
| Shreekant Dattathray Sawant | 00745968 | Centaur Pharmaceuticals Private Limited | Managing Director |
| Smita Abhayakumar Phal | 02887382 | Centaur Pharmaceuticals Private Limited | Whole-Time Director |
| Supriya Samar Desai | 07499177 | Centaur Pharmaceuticals Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Albert Tauro
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Albert Tauro
Albert Tauro currently holds 1 directorship: Centaur Pharmaceuticals Private Limited (Director, since 11 Aug 2016, revenue ₹1,060 Cr (FY 2025)).
Albert Tauro was first appointed on 08 Sep 2007 as Director at Cent Bank Home Finance Ltd. The most recent appointment on record is 08 Jan 2020 at Kharar Ludhiana Road Limited.
Albert Tauro held 7 earlier board appointments: Ashoka Buildcon Limited (Additional Director, 18 May 2012 to 24 Jul 2012); Viva Highways Limited (Director, 05 Sep 2015 to 11 Sep 2017); Ashoka Infrastructure Limited (Director, 07 Sep 2015 to 11 Sep 2017); Kharar Ludhiana Road Limited (Nominee Director, 08 Jan 2020 to 18 Nov 2020); Ranastalam Anandapuram Road Limited (Nominee Director, 07 Jan 2020 to 18 Nov 2020); and 2 more.
The current boards of Albert Tauro's companies include Pritam Maruti Khawale (Centaur Pharmaceuticals Private Limited), Rakhi Shridhar Kadam (Centaur Pharmaceuticals Private Limited), Sharadchandra Damodar Abhyankar (Centaur Pharmaceuticals Private Limited), Shivanand Dattatray Sawant (Centaur Pharmaceuticals Private Limited), Shreekant Dattathray Sawant (Centaur Pharmaceuticals Private Limited), Smita Abhayakumar Phal (Centaur Pharmaceuticals Private Limited), among others.